Drd2 taq1a polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers / Rosario López Rodríguez en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 555-562 Título : Drd2 taq1a polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers Tipo de documento: texto impreso Autores: Rosario López Rodríguez, Autor ; Manuel Román, Autor ; Jesús Novalbos, Autor Fecha de publicación: 2022 Artículo en la página: pp. 555-562 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Prolactina, Polimorfismo DRD2 Taq1A, Polimorfismo DRD3 Ser9Gly, Antipsicóticos Resumen: Hyperprolactinemia mediated by antagonism of dopaminergic neurotransmission in the pituitary gland is a common adverse effect of antipsychotics. Recent studies have suggested that polymorphisms of dopamine receptors can affect the therapeutic response to antipsychotics. Link: ./index.php?lvl=notice_display&id=29348 [artículo] Drd2 taq1a polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers [texto impreso] / Rosario López Rodríguez, Autor ; Manuel Román, Autor ; Jesús Novalbos, Autor . - 2022 . - pp. 555-562. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 555-562 Palabras clave: Prolactina, Polimorfismo DRD2 Taq1A, Polimorfismo DRD3 Ser9Gly, Antipsicóticos Resumen: Hyperprolactinemia mediated by antagonism of dopaminergic neurotransmission in the pituitary gland is a common adverse effect of antipsychotics. Recent studies have suggested that polymorphisms of dopamine receptors can affect the therapeutic response to antipsychotics. Link: ./index.php?lvl=notice_display&id=29348

Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers / Jesús Novalbos en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 504-511 Título : Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers Tipo de documento: texto impreso Autores: Jesús Novalbos, Autor ; Rosario López Rodríguez, Autor ; Manuel Román, Autor Fecha de publicación: 2022 Artículo en la página: pp. 504-511 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: CYP2D6, Risperidona, 9-hidroxirisperidona, Farmacogenética, Farmacocinética, Voluntarios sanos Resumen: The objective of this study was to analyze the relationship between CYP2D6 genotype and pharmacokinetics and pharmacodynamics of risperidone. Seventy-one healthy volunteers (36 women and 35 men) received a 1-mg single oral dose of risperidone. Six major CYP2D6 polymorphisms (CYP2D6*3, *4, *5, *6, *7, and *9) and the duplication were detected. Link: ./index.php?lvl=notice_display&id=29422 [artículo] Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers [texto impreso] / Jesús Novalbos, Autor ; Rosario López Rodríguez, Autor ; Manuel Román, Autor . - 2022 . - pp. 504-511. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 504-511 Palabras clave: CYP2D6, Risperidona, 9-hidroxirisperidona, Farmacogenética, Farmacocinética, Voluntarios sanos Resumen: The objective of this study was to analyze the relationship between CYP2D6 genotype and pharmacokinetics and pharmacodynamics of risperidone. Seventy-one healthy volunteers (36 women and 35 men) received a 1-mg single oral dose of risperidone. Six major CYP2D6 polymorphisms (CYP2D6*3, *4, *5, *6, *7, and *9) and the duplication were detected. Link: ./index.php?lvl=notice_display&id=29422

---

1 (1 - 2 / 2)